Shimadzu Corporation's share price rebounded at the end of October. The recent rise has been attributed to reports of the world's first automated metabolomics analysis system and the outlook for improved earnings.
The share price rose 3.1%, from ¥4,341 on 23 October to ¥4,476 on 30 October, and continued to move higher over the past 5 trading days. Interest in the price trend grew partly because trading volume surged on 27 and 29 October.
The development of the world's first automated metabolomics analysis system was reported on 21 October, after which the related news was gradually priced into the market. The share price has remained at a high level since then.
A golden cross, with the 25-day moving average crossing above the 75-day moving average, was detected on 21 October, coinciding with the recent upward phase.
Results for 1Q of the fiscal year ending March 2027 were released on 6 August, with revenue reaching a record ¥130.6 billion. The upward revision to the full-year forecast and the planned annual dividend of ¥70 have been cited as earnings-related factors supporting the share price.